Abstract: Antitumor acting platinum(II or IV) complexes of the general formula ##STR1## where B represents a phenyl-C.sub.1 -C.sub.4 -alkyl radical which is optionally substituted in the phenyl nucleus by the radical R.sub.1 and R.sub.1 is hydrogen, halogen, trihalogen methyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy or C.sub.2 -C.sub.6 -alkanoyloxy or where B together with the structural part H.sub.2 N-CR.sub.2 < forms a tetrahydroisoquinoline radical, if B contains benzyl and R.sub.2 hydrogen and the benzyl radical in the 2-position contains the CH.sub.2 -radical or where B together with the structural part --CR.sub.2 < represents a tetrahydronaphthyl radical in which one CH.sub.2 group is optionally replaced by oxygen, or where B together with the structural part --CR.sub.2 < represents a decahydronaphthyl radical or an indanyl radical; R.sub.2 represents hydrogen, C.sub.1 -C.sub.6 -alkyl, phenyl or phenyl-C.sub.1 -C.sub.4 -alkyl, it also being possible for the phenyl ring of this group R.
Type:
Grant
Filed:
November 25, 1992
Date of Patent:
August 24, 1993
Assignee:
Asta Pharma AG
Inventors:
Henri Brunner, Peter Hankofer, Friedrich Maiterth, Jurgen Engel, Wolfgang Schumacher, Peter Hilgard, Rainer Voegeli
Abstract: A method for the production of alkyl or alkaryl hydroxamic acids and/or salts wherein a C.sub.8 -C.sub.22 alcohol is employed with water as the solvent is disclosed as well as the resultant salt and/or acid solutions per se and their use in the flotation of non-sulfide minerals, preferably clay.
Abstract: Fungicidal derivatives of carboxyclic anilides of the formula ##STR1## in which X represents optionally alkyl-substituted cycloalkyl or optionally alkyl-substituted cycloalkenyl,Hal represents halogen, andY.sup.1, Y.sup.2 and Y.sup.3 independently of one another represent hydrogen, halogen, optionally halogen-substituted alkyl, optionally halogen-substituted alkoxy or optionally halogen-substituted alkylthio, andZ represents the groups COOR.sup.2 or COR.sup.1, whereR.sup.1 and R.sup.2 are identical or different and represent optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, polyalkoxyalkyl and optionally substituted cycloalkyl, optionally substituted phenyl, optionally substituted phenylalkyl or substituted phenoxyalkyl.
Type:
Grant
Filed:
August 17, 1992
Date of Patent:
August 17, 1993
Assignee:
Bayer Aktiengesellschaft
Inventors:
Bernd-Wieland Kruger, Klaus Sasse, Wilhelm Brandes
Abstract: A water-immiscible organic extractant system can economically be used to recover citric acid from molasses fermenter beer containing a high salt content by using a process combination of passing the aqueous raffinate from the citric acid extraction step through a basic anion-exchange resin to adsorb residual citric acid and release citrate anions from previously formed salt cation-citrate compounds. Trisodium citrate is then eluted from the resin by passing aqueous sodium hydroxide therethrough.
Type:
Grant
Filed:
October 9, 1992
Date of Patent:
August 17, 1993
Assignee:
Miles, Inc.
Inventors:
Timothy A. Bemish, John P. Chiang, Bhalchandra H. Patwardhan, David J. Solow
Abstract: A process is disclosed for the carbonylation of an organic compound selected from the group consisting of an olefin, an alcohol, an acid and an ester. In this process the organic compound is reacted with carbon monoxide in the presence of a Group VIII metal-containing catalyst. The liquid carbonylation product solution of this reaction is conveyed to a separation zone maintained at a lower total pressure than is the pressure in the reaction zone. Simultaneously with the conveyance of the liquid product solution to the separation zone is the introduction therein of a carbon monoxide-containing gaseous stream, the carbon monoxide therein contributing a partial pressure of up to 30 psia of the total pressure in said separation zone. A portion of the liquid carbonylation product solution is flashed and removed from the separation zone. The unflashed liquid carbonylation product solution is recycled back into the reaction zone.
Abstract: The present invention relates to a process for the preparation of 2-amino-3-chlorobenzoic acid by dissolving 1 mol of 2,3-dichlorobenzoic acid in about 400 to about 2000 parts of water with at least the equimolar amount of an alkali metal hydroxide or with an aqueous solution of the equimolar amount of an alkali metal hydroxide, and subsequently reacting it with about 500 to about 2500 mol % of ammonia at temperatures of about 150.degree. to about 220.degree. C. in the presence of copper bronze, copper(I) salts and/or copper(II) salts.
Abstract: Optionally active Lewis acid catalysts of the early transition metals which are useful in the catalysis of asymmetric additions have been prepared. The catalyst complexes comprise an alkoxide of a group IV or group V metal and an optically active trialkanolamine or dialkanolamine ligand.
Abstract: A process for the catalytic gas-phase oxidation of methacrolein to methacrylic acid in a fixed-bed reactor with contacting tubes, at elevated temperature on catalytically active oxides with a conversion of methacrolein for a single pass of from 40 to 95 mol%, wherein the reaction temperature in the flow direction along the contacting tubes in a first reaction zone from entry of the starting reaction gases containing the reactants into the contacting tubes is from 280 to 340.degree. C. until a methacrolein conversion of from 20 to 40% is reached, and the reaction temperature is subsequently reduced by a total of from 5.degree. to 40.degree. C., abruptly or successively in steps or continuously along the contacting tubes until a methacrolein conversion of from 45 to 95% has been reached, with the proviso that the reaction temperature in this second reaction zone is not lower than 260.degree. C.
Type:
Grant
Filed:
September 22, 1992
Date of Patent:
July 27, 1993
Assignee:
BASF Aktiengesellschaft
Inventors:
Ulrich Hammon, Klaus Herzog, Hans-Peter Neumann
Abstract: A compound of formula: ##STR1## in which X.sup.1 is a reactive group that can react to form a covalent bond with a reactive group on the surface of a material to be rendered biocompatible, X.sup.2 is a group -O.sup..crclbar. or a precursor of such a group, n is 2, 3 or 4, Y is a group --N.sup..sym. R.sub.3 A.sup..crclbar. wherein each R, which may be the same or different, is a C.sub.1 -C.sub.4 alkyl group and A.sup..crclbar. is an anion present when X.sup.2 is an electrically neutral group or Y is ##STR2## wherein R.sup.1 together with X.sup.2 forms a direct bond between the nitrogen and the phosphorus atoms.
Abstract: A process for purifying an iodide-contaminated carboxylic acid and/or anhydride fraction obtained by liquid phase carbonylation using a carbonylation catalyst, an iodine-containing promoter and optional iodine-containing copromoter comprises vaporizing the fraction after it has been freed of catalyst, feedstock and promoter components to produce a vapor acid and/or anhydride fraction having reduced iodide contamination.
Abstract: Adipic acid is selectively prepared, in good yields, by reacting at least one pentenic acid with water and carbon monoxide, the partial pressure of which, measured at 25.degree. C., being less than or equal to 12 bar, in the presence of a catalytically effective amount of a rhodium-based catalyst and at least one iodine-containing promoter therefor, at a temperature ranging from 100.degree. to 240.degree. C. and at superatmospheric pressure, and in a liquid reaction medium which comprises at least one hydrocarbon or chlorocarbon solvent, whether a saturated aliphatic or cycloaliphatic hydrocarbon, aromatic hydrocarbon or chlorinated derivative thereof.
Abstract: A process for the production of fluorobenzaldehydes which comprises reacting a chlorobenzaldehyde with an alkali fluoride in a dipolar aprotic medium.
Abstract: The use is disclosed of compounds of general formula ##STR1## wherein: Y is hydrogen or methyl andR is an unsubstituted or substituted alkyl group selected from methyl, ethyl and isopropyl,and the pharmacologically acceptable salts thereof, for treating myopathies, neuronal degeneration and some pathologies affecting the liver, skeletal muscles and myocardium.The compounds can be administered orally or parenterally.
Abstract: This invention relates to an improved process for synthesizing carboxylic acids by the carbonylation of alcohol. An alcohol such as methanol is reacted with carbon monoxide in a liquid reaction medium containing a rhodium (Rh) catalyst stabilized with an haloacetic acid, especially trifluoroacetic acid (TFAA), along with alkyl iodide such as methyl iodide (MeI) in specified proportions. The present reaction system is not only characterized by unexpectedly high catalyst stability, but also characterized by the high reaction rate for the formation of acetic acid. The improvement resides in the employment of trifluoroacetic acid as the catalyst promoter at a temperature from 180.degree. C. to 200.degree. C. The primary advantage of the catalyst system of this invention is the enhancement of the rate of carbonylation. The other advantage of the catalyst system is that they are readily soluble and thermally stable, making them resistant to deposition.
Type:
Grant
Filed:
February 24, 1992
Date of Patent:
July 13, 1993
Assignee:
China Petrochemical Development Corporation
Abstract: There is disclosed a process for producing lower alkyl 2-keto-L-gulonate which comprises reacting 2-keto-L-gulonic acid with a lower alcohol in the presence of an acid, and simultaneously distilling off the resulting water together with the lower alcohol while continuously introducing a lower alcohol. By using the lower alkyl 2-keto-L-gulonate thus produced, L-ascorbate can be prepared in high purity and high yield.
Abstract: Adipic acid is selectively prepared by reacting water and carbon monoxide with at least one pentenic acid, in the presence of an iridium-based catalyst and at least one iodine-containing promoter therefor, at an elevated temperature, at a pressure greater than atmospheric pressure, in a reaction medium comprising at least one saturated aliphatic carboxylic acid, ethylenically unsaturated aliphatic carboxylic acid or aromatic carboxylic acid having not more than 20 carbon atoms, with the I/Ir atomic ratio being less than 10.
Type:
Grant
Filed:
April 24, 1992
Date of Patent:
July 13, 1993
Assignee:
Rhone-Poulenc Chimie
Inventors:
Philippe Denis, Jean-Michel Grosselin, Francois Metz
Abstract: This invention is a process for the production of trialkyl acetic acids, particularly of pivalic acid, from branched olefins, particularly isobutene, and carbon monoxide using catalytic amounts of a Lewis acid such as boron trifluoride.
Type:
Grant
Filed:
April 9, 1991
Date of Patent:
July 13, 1993
Assignee:
Catalytica Inc.
Inventors:
Michael A. Richard, William A. Sanderson
Abstract: Procedure for obtaining acetic acid derivatives (I) where R.sub.1 and R.sub.2 are H or groups --CH.sub.2 --COOH by oxidation of (II) where R and R' are H or groups of --CH.sub.2 --CH.sub.2 OH with O.sub.2 or a gas that contains it, in the presence of an metal hydroxide, demineralized water and Cu-Raney. The reaction is carried out keeping constant a partial pressure of oxygen below 20 Kg/cm.sup.2, inside the reactor. The acids (I) obtained as soluble salts, can be isolated and purified by chemical or electrochemical means.Examples of acids (I) are glycine, iminediacetic acid and nitricetriacetic acid, useful as nutrients and in the synthesis of herbicides.
Type:
Grant
Filed:
June 12, 1992
Date of Patent:
July 6, 1993
Assignee:
Ercros S.A.
Inventors:
Jose Ochoa Gomez, Juan Martin Ramon, Jose Sanchez Sanchez, Asuncion De Diego Zori
Abstract: A method of purifying .alpha.-L-aspartyl-L-phenylalanine methyl ester as a hydrochloride salt thereof which comprises:i) contacting a mixture of .alpha.-L-aspartyl-L-phenylanaline methyl ester and .beta.-L-aspartyl-L-phenylalanine methyl ester with an aqueous medium containing (a) hydrogen chloride in an amount not more than ca. 2 mol., per liter of said aqueous medium, but not less than 1 mol., per mole of said of said mixture of .alpha.-L-aspartyl-L-phenylalanine methyl ester and .beta.-L-aspartyl-L-phenylalanine methyl ester, and (b) an inorganic chloride selected from the group consisting of NaCl, KCl, NH.sub.4 Cl, CaCl.sub.2, and ZnCl.sub.2 in an amount of at least ca. 50 g., per liter of said aqueous medium, to form crystals of .alpha.-L-aspartyl-L-phenylalanine methyl ester hydrochloride, andii) recovering the .alpha.-L-aspartyl-L-phenylalanine methyl ester hydrochloride crystals therefrom.
Abstract: Intermediates and methods for producing intermediates for use in preparing 9-(1,3-dihydroxy-2-propoxymethyl)-guanine and esters and ethers thereof.
Type:
Grant
Filed:
April 26, 1988
Date of Patent:
July 6, 1993
Assignee:
Syntex (U.S.A.) Inc.
Inventors:
David J. Morgans, Jr., Harlan H. Chapman